AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices,
The agreement, which entails offering “most-favored nation” pricing, follows Pfizer’s deal to reduce prices for its drugs sold in the Medicaid program and through a direct-purchasing service to be branded TrumpRx.
In-Article-1
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
In-Article-2 Desktop Banner (This ad will be displayed on screens larger than 992p
Mobile Banner (This ad will be displayed on screens smaller than 992px)
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Carver
Carver who carves the news
